BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10352240)

  • 1. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.
    Hostager BS; Bishop GA
    J Immunol; 1999 Jun; 162(11):6307-11. PubMed ID: 10352240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
    Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
    J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
    Hsing Y; Hostager BS; Bishop GA
    J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; PĆ¼schner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75.
    Declercq W; Denecker G; Fiers W; Vandenabeele P
    J Immunol; 1998 Jul; 161(1):390-9. PubMed ID: 9647248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.
    Gardam S; Sierro F; Basten A; Mackay F; Brink R
    Immunity; 2008 Mar; 28(3):391-401. PubMed ID: 18313334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF2 and p38 are involved in B cells CD40-mediated APE/Ref-1 nuclear translocation: a novel pathway in B cell activation.
    Merluzzi S; D'Orlando O; Leonardi A; Vitale G; Pucillo C
    Mol Immunol; 2008 Jan; 45(1):76-86. PubMed ID: 17599408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40-mediated signals inhibit the binding of TNF receptor-associated factor 2 to the CD40 cytoplasmic domain.
    Chaudhuri A; Orme S; Eilam S; Cherayil BJ
    J Immunol; 1997 Nov; 159(9):4244-51. PubMed ID: 9379019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.
    Yamamoto H; Kishimoto T; Minamoto S
    J Immunol; 1998 Nov; 161(9):4753-9. PubMed ID: 9794406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40-mediated signaling in B cells. Balancing cell survival, growth, and death.
    Kehry MR
    J Immunol; 1996 Apr; 156(7):2345-8. PubMed ID: 8786287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation.
    Georgopoulos NT; Steele LP; Thomson MJ; Selby PJ; Southgate J; Trejdosiewicz LK
    Cell Death Differ; 2006 Oct; 13(10):1789-801. PubMed ID: 16429118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes.
    Xie P; Hostager BS; Bishop GA
    J Exp Med; 2004 Mar; 199(5):661-71. PubMed ID: 14981114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.
    Aicher A; Shu GL; Magaletti D; Mulvania T; Pezzutto A; Craxton A; Clark EA
    J Immunol; 1999 Dec; 163(11):5786-95. PubMed ID: 10570261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct molecular mechanism for initiating TRAF6 signalling.
    Ye H; Arron JR; Lamothe B; Cirilli M; Kobayashi T; Shevde NK; Segal D; Dzivenu OK; Vologodskaia M; Yim M; Du K; Singh S; Pike JW; Darnay BG; Choi Y; Wu H
    Nature; 2002 Jul; 418(6896):443-7. PubMed ID: 12140561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct contributions of different CD40 TRAF binding sites to CD154-induced dendritic cell maturation and IL-12 secretion.
    Mackey MF; Wang Z; Eichelberg K; Germain RN
    Eur J Immunol; 2003 Mar; 33(3):779-89. PubMed ID: 12616498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
    Eliopoulos AG; Dawson CW; Mosialos G; Floettmann JE; Rowe M; Armitage RJ; Dawson J; Zapata JM; Kerr DJ; Wakelam MJ; Reed JC; Kieff E; Young LS
    Oncogene; 1996 Nov; 13(10):2243-54. PubMed ID: 8950992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.